Page last updated: 2024-08-24

2-methoxyestradiol and Experimental Hepatoma

2-methoxyestradiol has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carr, BI; Kar, S; Wang, M	1

Other Studies

1 other study(ies) available for 2-methoxyestradiol and Experimental Hepatoma

Article	Year
2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:5 Topics: 2-Methoxyestradiol; Animals; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; cdc25 Phosphatases; Cell Cycle; Cell Division; Cell Proliferation; Cells, Cultured; DNA; Estradiol; G2 Phase; Hepatocytes; Immunoprecipitation; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Rats; Rats, Inbred F344; Tubulin Modulators	2008

Article

Year

2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.

Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:5

Topics: 2-Methoxyestradiol; Animals; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; cdc25 Phosphatases; Cell Cycle; Cell Division; Cell Proliferation; Cells, Cultured; DNA; Estradiol; G2 Phase; Hepatocytes; Immunoprecipitation; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Rats; Rats, Inbred F344; Tubulin Modulators

2008